ELIKA KAMDAR: Open Payments
NPI 1578998589 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,325 in 130 payments from 19 companies in 2025. Trend: 2023 $2,096 · 2024 $3,124 · 2025 $2,325
Food & beverage: $2,325
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $679 |
| Janssen Biotech, Inc. | 14 | $255 |
| GENZYME CORPORATION | 6 | $224 |
| MAYNE PHARMA COMMERCIAL LLC | 28 | $196 |
| Galderma Laboratories, L.P. | 12 | $185 |
| Regeneron Healthcare Solutions, Inc. | 5 | $172 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $116 |
| PFIZER INC. | 5 | $109 |
| Arcutis Biotherapeutics, Inc. | 3 | $68 |
| LEO Pharma Inc. | 2 | $53 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, TREMFYA, NEMLUVIO, ILUMYA, CIBINQO, Zoryve.
Industry payments across CA — which companies pay providers there.
